A Multicenter Prospective Study of TACE Combined with Lenvatinib and Camrelizumab for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
CANCER MEDICINE(2023)
Key words
camrelizumab,hepatocellular carcinoma,lenvatinib,portal vein tumor thrombus,transarterial chemoembolization
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined